Abstract
Pancreatic cancer is one of the most common human cancers with very low survival rate. So far, the difficulties to make early diagnosis and find curative therapy for this malignant disease remain challenging. Considering Chinese medicine with a long history of clinical application in treating various human diseases, it has been now introduced into the anti-cancer treatment and begun to attract attentions of researchers worldwide. Here, we summarize the recent studies on the anti-tumor activity of Chinese medicine in human pancreatic cancer and the potential molecular mechanisms.
Keywords: Chinese medicine, pancreatic cancer, therapy.
Current Signal Transduction Therapy
Title:Chinese Medicine: A Novel Therapeutic Option for Pancreatic Cancer
Volume: 9 Issue: 1
Author(s): Ping Yan, Yongxing Cao and Xiaotian Sun
Affiliation:
Keywords: Chinese medicine, pancreatic cancer, therapy.
Abstract: Pancreatic cancer is one of the most common human cancers with very low survival rate. So far, the difficulties to make early diagnosis and find curative therapy for this malignant disease remain challenging. Considering Chinese medicine with a long history of clinical application in treating various human diseases, it has been now introduced into the anti-cancer treatment and begun to attract attentions of researchers worldwide. Here, we summarize the recent studies on the anti-tumor activity of Chinese medicine in human pancreatic cancer and the potential molecular mechanisms.
Export Options
About this article
Cite this article as:
Yan Ping, Cao Yongxing and Sun Xiaotian, Chinese Medicine: A Novel Therapeutic Option for Pancreatic Cancer, Current Signal Transduction Therapy 2014; 9 (1) . https://dx.doi.org/10.2174/157436240901140924103948
DOI https://dx.doi.org/10.2174/157436240901140924103948 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Preclinical Evaluation of New Anthracyclines
Current Medicinal Chemistry The Antiproliferative and Pro-apoptotic Effects of Methoxyamine on Pediatric Medulloblastoma Cell Lines Exposed to Ionizing Radiation and Chemotherapy
Central Nervous System Agents in Medicinal Chemistry Synthesis and Biological Evaluation of Novel Heterocyclic Imines Linked Coumarin- Thiazole Hybrids as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Complex Interactions between Phytochemicals. The Multi-Target Therapeutic Concept of Phytotherapy
Current Drug Targets Exploring Old Drugs for the Treatment of Hematological Malignancies
Current Medicinal Chemistry T Lymphocytes as Targets of Statins: Molecular Mechanisms and Therapeutic Perspectives
Inflammation & Allergy - Drug Targets (Discontinued) Natural Products Based Anticancer Agents
Mini-Reviews in Organic Chemistry Metabolic Basis of Polycystic Ovarian Syndrome; Indications for Biochemical Screening
Endocrine, Metabolic & Immune Disorders - Drug Targets <i>In Vivo</i> Anti-Tumor Effects of Flavokawain A in 4T1 Breast Cancer Cell-Challenged Mice
Anti-Cancer Agents in Medicinal Chemistry Nanocarriers for Tracking and Treating Diseases
Current Medicinal Chemistry A Review on Anticancer Activities of Thiophene and Its Analogs
Mini-Reviews in Medicinal Chemistry Resistance of Cancer Cells to Targeted Therapies Through the Activation of Compensating Signaling Loops
Current Signal Transduction Therapy Aliphatic Nucleophilic Radiofluorination
Current Radiopharmaceuticals Recent Advances of Silver Nanoparticles in Cancer Diagnosis and Treatment
Anti-Cancer Agents in Medicinal Chemistry Gene Therapy in Lung Transplantation
Current Gene Therapy Bioactivity of Hybrid Polymeric Magnetic Nanoparticles and Their Applications in Drug Delivery
Current Pharmaceutical Design Two Panels of Steroid Receptor Luciferase Reporter Cell Lines for Compound Profiling
Combinatorial Chemistry & High Throughput Screening Recent Advances of Nanotechnology in the Diagnosis and Therapy of Triple- Negative Breast Cancer (TNBC)
Current Pharmaceutical Biotechnology Peptide Activators of the p53 Tumor Suppressor
Current Pharmaceutical Design Axillary Mass Turned Out to be A Phyllodes Tumour in An Ectopic Breast Tissue– A Rare Case Report
New Emirates Medical Journal